corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel)
Comprehensive product details for sourcing and verification.
| NDC 11 | 49281-0286-10 |
|---|---|
| Product NDC | 49281-0286 |
| Generic Drug Name | corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen |
| Brand Name | Daptacel |
| Manufacturer | Sanofi Pasteur Inc. |
| Strength | 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular |
| Package Quantity | 10 Vial |
| Package Description | 10 VIAL in 1 PACKAGE (49281-286-10) / .5 mL in 1 VIAL (49281-286-58) |
| Active Ingredients | Bordetella Pertussis Filamentous Hemagglutinin Antigen (Formaldehyde Inactivated); Bordetella Pertussis Fimbriae 2/3 Antigen; Bordetella Pertussis Pertactin Antigen; Bordetella Pertussis Toxoid Antigen (Glutaraldehyde Inactivated); Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (Formaldehyde Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection is tracked under NDC 49281-0286-10 and rolls up into product family 49281-0286. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Vial.
- Manufacturer: Sanofi Pasteur Inc..
- Dosage form: Injection.
- Family size: 3 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public sources include one strong historical shortage/supply update plus exact product identification sources for DAPTACEL NDC 49281-286-10.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel), NDC 49281-0286-10, is a Sanofi Pasteur Inc. 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL injection presentation packaged as 10 Vial. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 49281-0286-10.
- Digits-only NDC 11: 49281028610.
- Possible 10-digit display format: 49281-286-10 (4928128610).
Helpful product links
- Search by brand name: Daptacel.
- Exact NDC 11: 49281-0286-10.
- Product family NDC: 49281-0286.
- Other package sizes in this family: 1 Vial, 5 Vial.
- Compare related presentations: corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel).